Mustang Bio Inc (MBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 109,618 | 120,879 | 129,923 | 129,371 | 97,804 |
| Receivables | 50 | 41 | 32 | 17 | 15 |
| TOTAL | $111,706 | $121,948 | $131,341 | $130,969 | $99,534 |
| Non-Current Assets | |||||
| PPE Net | 11,052 | 10,437 | 9,510 | 8,538 | 8,028 |
| Other Non-Current Assets | 2,412 | 2,321 | 2,356 | 2,315 | 2,338 |
| TOTAL | $13,464 | $12,758 | $11,866 | $10,853 | $10,366 |
| Total Assets | $125,170 | $134,706 | $143,207 | $141,822 | $109,900 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,744 | 9,834 | 5,766 | 5,959 | 8,747 |
| Accrued Expenses | 723 | 296 | 249 | 343 | 490 |
| TOTAL | $10,815 | $10,459 | $6,361 | $6,586 | $9,515 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,685 | 1,763 | 1,821 | 1,875 | 1,950 |
| TOTAL | $1,955 | $2,033 | $1,821 | $1,875 | $1,950 |
| Total Liabilities | $12,770 | $12,492 | $8,182 | $8,461 | $11,465 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 134 | 125 | 122 | 116 | 114 |
| Common Shares | 4,338 | 46 | 194 | 226 | 7,946 |
| Retained earnings | -251,844 | -231,795 | -214,790 | -200,431 | -185,474 |
| TOTAL | $112,400 | $122,214 | $135,025 | $133,361 | $98,435 |
| Total Liabilities And Equity | $125,170 | $134,706 | $143,207 | $141,822 | $109,900 |